Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Lascoux, Cecile"'
Autor:
Duval, Xavier, Mentré, France, Rey, Elisabeth, Auleley, Solange, Peytavin, Gilles, Biour, Michel, Métro, Annie, Goujard, Cecile, Taburet, Anne-Marie, Lascoux, Cecile, Panhard, Xaviere, Tréluyer, Jean-Marc, Salmon-Céron, Dominique, Study Group, The Cophar 2
Publikováno v:
Fundamental and Clinical Pharmacology
Fundamental and Clinical Pharmacology, Wiley, 2009, 23 (4), pp.491-500. ⟨10.1111/j.1472-8206.2009.00693.x⟩
Fundamental & Clinical Pharmacology
Fundamental & Clinical Pharmacology, 2009, 23 (4), pp.491-500. ⟨10.1111/j.1472-8206.2009.00693.x⟩
Fundamental & Clinical Pharmacology, Wiley, 2009, 23 (4), pp.491-500. ⟨10.1111/j.1472-8206.2009.00693.x⟩
Fundamental & Clinical Pharmacology, 2009, 23 (4), pp.491-500. <10.1111/j.1472-8206.2009.00693.x>
Fundamental and Clinical Pharmacology, Wiley, 2009, 23 (4), pp.491-500. ⟨10.1111/j.1472-8206.2009.00693.x⟩
Fundamental & Clinical Pharmacology
Fundamental & Clinical Pharmacology, 2009, 23 (4), pp.491-500. ⟨10.1111/j.1472-8206.2009.00693.x⟩
Fundamental & Clinical Pharmacology, Wiley, 2009, 23 (4), pp.491-500. ⟨10.1111/j.1472-8206.2009.00693.x⟩
Fundamental & Clinical Pharmacology, 2009, 23 (4), pp.491-500. <10.1111/j.1472-8206.2009.00693.x>
International audience; As a result of high inter-patient variability, and efficacy-concentration and toxicity-concentration relationships, optimization of HIV-protease inhibitor (PI) doses based on plasma concentrations could be beneficial. During a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::351cbff8ce3d6af7d9439de66d6fed16
https://www.hal.inserm.fr/inserm-00416211
https://www.hal.inserm.fr/inserm-00416211
Autor:
Duval X; Inserm CIC 007, Hôpital Bichat, Paris, France. xavier.duval@bch.aphp.fr, Mentré F, Rey E, Auleley S, Peytavin G, Biour M, Métro A, Goujard C, Taburet AM, Lascoux C, Panhard X, Tréluyer JM, Salmon-Céron D
Publikováno v:
Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2009 Aug; Vol. 23 (4), pp. 491-500.